Kbc Group Nv Abb Vie Inc. Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Abb Vie Inc. stock. As of the latest transaction made, Kbc Group Nv holds 1,092,049 shares of ABBV stock, worth $192 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

1,092,049

Previous 682,835 59.93%

Holding current value

$192 Million

Previous $117 Million 84.14%

% of portfolio

0.65%

Previous 0.35%

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$163.84 - $199.33 $67 Million - $81.6 Million	409,214 Added 59.93%	1,092,049 $216 Million
Q2 2024 Jul 17, 2024	SELL	$154.79 - $180.76 $22.9 Million - $26.7 Million	-147,918 Reduced 17.81%	682,835 $117 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $38.6 Million - $44 Million	-241,488 Reduced 22.52%	830,753 $151 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $24.7 Million - $27.8 Million	179,143 Added 20.06%	1,072,241 $166 Million
Q3 2023 Feb 15, 2024	BUY	$133.59 - $154.65 $16.9 Million - $19.6 Million	126,654 Added 14.18%	1,019,752 $152 Million
Q2 2023 Feb 15, 2024	SELL	$132.51 - $164.9 $71.5 Million - $89 Million	-539,585 Reduced 37.66%	893,098 $120 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $22.7 Million - $28.3 Million	-171,603 Reduced 16.12%	893,098 $120 Million
Q1 2023 Feb 14, 2024	SELL	$144.61 - $166.54 $46.7 Million - $53.7 Million	-322,730 Reduced 23.16%	1,070,465 $171 Million
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $52.8 Million - $60.8 Million	-364,848 Reduced 25.52%	1,064,701 $170 Million
Q4 2022 Feb 14, 2024	BUY	$138.31 - $165.87 $24 Million - $28.8 Million	173,639 Added 14.24%	1,393,195 $225 Million
Q3 2022 Feb 15, 2024	BUY	$134.21 - $153.93 $48.4 Million - $55.5 Million	360,442 Added 33.62%	1,432,683 $192 Million
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $29.4 Million - $33.7 Million	218,863 Added 18.08%	1,429,549 $192 Million
Q2 2022 Feb 14, 2024	BUY	$137.62 - $174.96 $61.8 Million - $78.6 Million	449,340 Added 58.34%	1,219,556 $187 Million
Q2 2022 Jul 26, 2022	BUY	$137.62 - $174.96 $60.6 Million - $77.1 Million	440,470 Added 57.19%	1,210,686 $185 Million
Q1 2022 Feb 14, 2024	BUY	$131.98 - $163.75 $26.9 Million - $33.4 Million	203,722 Added 35.96%	770,216 $125 Million
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $26.9 Million - $33.4 Million	203,722 Added 35.96%	770,216 $125 Million
Q4 2021 Feb 14, 2024	SELL	$107.43 - $135.93 $54.3 Million - $68.7 Million	-505,747 Reduced 47.17%	566,494 $76.7 Million
Q4 2021 Feb 03, 2022	BUY	$107.43 - $135.93 $21.1 Million - $26.7 Million	196,338 Added 53.04%	566,494 $76.7 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $2.7 Million - $3.06 Million	-25,359 Reduced 6.41%	370,156 $39.9 Million
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $1.21 Million - $1.35 Million	11,488 Added 2.99%	395,515 $44.6 Million
Q1 2021 Apr 26, 2021	SELL	$102.3 - $112.62 $9.08 Million - $10 Million	-88,762 Reduced 18.77%	384,027 $41.6 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $14.4 Million - $19.5 Million	-179,077 Reduced 27.47%	472,789 $50.7 Million
Q3 2020 Oct 28, 2020	SELL	$85.91 - $100.83 $59.8 Million - $70.1 Million	-695,571 Reduced 51.62%	651,866 $57.1 Million
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $44.8 Million - $60 Million	610,839 Added 82.93%	1,347,437 $132 Million
Q1 2020 May 04, 2020	BUY	$64.5 - $97.79 $12.7 Million - $19.3 Million	197,289 Added 36.58%	736,598 $56.1 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $7.59 Million - $9.49 Million	-105,174 Reduced 16.32%	539,309 $47.8 Million
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $40.4 Million - $48.5 Million	640,854 Added 17659.24%	644,483 $48.8 Million
Q2 2019 Dec 03, 2019	SELL	$65.7 - $83.98 $39 Million - $49.8 Million	-593,124 Reduced 99.39%	3,629 $264,000
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $39 Million - $49.8 Million	593,334 Added 17354.02%	596,753 $0
Q1 2019 Dec 03, 2019	SELL	$77.14 - $90.79 $42.8 Million - $50.4 Million	-555,344 Reduced 99.39%	3,419 $276,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $42.9 Million - $50.5 Million	556,779 Added 28063.46%	558,763 $0
Q4 2018 Dec 03, 2019	SELL	$77.85 - $96.01 $22.7 Million - $27.9 Million	-291,021 Reduced 99.32%	1,984 $183,000
Q4 2018 Jan 31, 2019	BUY	$77.85 - $96.01 $22.7 Million - $27.9 Million	291,021 Added 14668.4%	293,005 $27 Million
Q3 2018 Dec 03, 2019	SELL	$88.91 - $98.84 $32.3 Million - $36 Million	-363,793 Reduced 99.46%	1,984 $188,000
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $32.3 Million - $36 Million	363,793 Added 18336.34%	365,777 $0
Q2 2018 Dec 03, 2019	SELL	$89.78 - $106.23 $22.3 Million - $26.4 Million	-248,299 Reduced 99.21%	1,984 $184,000
Q2 2018 Aug 03, 2018	BUY	$89.78 - $106.23 $22.3 Million - $26.4 Million	248,299 Added 12515.07%	250,283 $0
Q1 2018 Dec 03, 2019	SELL	$92.01 - $123.21 $72 Million - $96.4 Million	-782,469 Reduced 99.75%	1,984 $188,000
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $72 Million - $96.4 Million	782,469 Added 39438.96%	784,453 $0
Q4 2017 Dec 03, 2019	SELL	$89.56 - $98.21 $85.1 Million - $93.3 Million	-949,981 Reduced 99.79%	1,984 $192,000
Q4 2017 Feb 07, 2018	BUY	$89.56 - $98.21 $85.1 Million - $93.3 Million	949,981 Added 47882.11%	951,965 $0
Q3 2017 Dec 03, 2019	SELL	$69.85 - $89.22 $92.7 Million - $118 Million	-1,327,695 Reduced 99.85%	1,984 $176,000
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $92.7 Million - $118 Million	1,327,695 Added 66920.11%	1,329,679 $0
Q2 2017 Dec 03, 2019	BUY	N/A	1,984	1,984 $144,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account